Maternal mortality

Current Opinion in Anaesthesiology

Volumn 25, Issue 3, 2012, Pages 277-285

  Mhyre, Jill M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

maternal mortality; obstetric hemorrhage; preeclampsia; racial disparity; venous thromboembolism

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; HEPARIN; HYDRALAZINE; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM SULFATE; NIFEDIPINE; NORADRENALIN;

AFRICAN AMERICAN; AMNION FLUID EMBOLISM; ANESTHESIST; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; BLEEDING; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; DEVELOPED COUNTRY; DYSPNEA; ENVIRONMENTAL EXPOSURE; ETHNIC DIFFERENCE; FEMALE GENITAL TRACT INFECTION; FLUID RESUSCITATION; FRANCE; HEALTH CARE QUALITY; HEALTH SURVEY; HEART ARREST; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; HYPOTENSION; INFECTION RISK; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; INTRASCAPULAR PAIN; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MULTIPLE PREGNANCY; NETHERLANDS; NEW ZEALAND; OBSTETRIC ANESTHESIA; OBSTETRIC HEMORRHAGE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PRIORITY JOURNAL; PUERPERAL INFECTION; RACE DIFFERENCE; REVIEW; SAFETY; SEX DIFFERENCE; SEX RATIO; SOCIAL ASPECT; TACHYPNEA; THORAX PAIN; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS; THROMBOSIS PREVENTION; UNITED KINGDOM; UNITED STATES; VENOUS THROMBOEMBOLISM; WHEEZING;

ADULT; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; MATERNAL MORTALITY; MINORITY GROUPS; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY, MULTIPLE; RISK; UNITED STATES; WOMEN; WORLD HEALTH ORGANIZATION;

EID: 84861094298     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3283530580     Document Type: Review

References (56)

1. WHO, UNICEF, UNFPA, The World Bank. Trends in maternal mortality 1990-2008: estimates developed by WHO, UNICEF, UNFPA and The World Bank. Geneva: World Health Organization; 2010. This report contains the official WHO estimates for the maternal mortality ratio for 181 countries around the world, and tracks progress towards Millenium Development Goal 5, to reduce global maternal mortality by 75% between 1990 and 2015.
2. Schutte JM, Steegers EA, Schuitemaker NW, et al. Rise in maternal mortality in the Netherlands. BJOG 2010;117:399-406. The confidential enquiry into maternal death in the Netherlands found that preeclampsia was the leading cause of maternal death among Dutch women between 1993 and 2005, with the majority of these cases due to cerebral hemorrhage or encephalopathy in the setting of severe hypertension.
3. Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010;375:1609-1623. This study analyzes all available data sources from both low and high-income countries, and uses sophisticated analytic methods to generate updated estimates for the maternal mortality ratio for 181 countries each year between 1980 and 2008. Further analysis estimated the specific impact of HIV on the number of global maternal deaths.
4. Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer:2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118 (Suppl 1) :1-203. The Confidential Enquiry in the UK is the gold standard for maternal mortality review. In this triennial report, chapters on sepsis, anesthesia, cardiovascular disease, and critical care are particularly helpful for the anesthesiologist.
5. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010;116:1302-1309. This publication from the Pregnancy Mortality Surveillance System provides the most comprehensive and current national review of maternal deaths in the USA. Currently seven categories each contribute between 10 and 13% of all pregnancyrelated deaths: hemorrhage, venous thromboembolism, hypertensive disorders of pregnancy, infection, cardiomyopathy, other cardiovascular disorders, and other medical disorders.
6. Lewis G, editor. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer:2003-2005. 2007. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH.
7. Lisonkova S, Bartholomew S, Rouleau J, et al. Temporal trends in maternal mortality in Canada I: estimates based on vital statistics data. J Obstet Gynaecol Can 2011;33:1011-1019.
8. Hoyert DL. Maternal mortality and related concepts. Vital Health Stat 2007;3:1-13.
9. Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol 2003;101:289-296.
10. Deneux-Tharaux C, Berg C, Bouvier-Colle MH, et al. Underreporting of pregnancy-related mortality in the United States and Europe. Obstet Gynecol 2005;106:684-692.
11. Mackay AP, Berg CJ, Liu X, et al. Changes in pregnancy mortality ascertainment: United States, 1999-2005. Obstet Gynecol 2011;118:104-110. This study analyzes the impact of standard pregnancy check-box on maternal mortality ascertainment in the USA by comparing the 2005 maternal mortality statistics for those states with the standard check-box on the state death certificate, with statistics for those states with nonstandard pregnancy questions, and those with no questions about pregnancy.
12. Minisño A, Murphy S, Xu J, Kochanek K. Deaths: final data for 2008. Natl Vital Stat Rep 2011;59:1-157.
13. Mackay A. Identifying pregnancy deaths in the United States: an update. Presented at Maternal Mortality Review meeting and Special InterestGroup at ACOG's Annual Meeting. Washington, DC; 2011.
14. Main EK. Maternal mortality: new strategies for measurement and prevention. Curr Opin Obstet Gynecol 2010;22:511-516. This review by the head of the California Maternal Quality Care Collaborative is directed towards the obstetrican and provides an overview of maternal mortality measurement, and opportunities for improvement.
15. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol 2010;202:353e351-e356.
16. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg 2010;110:1368-1373.
17. Kuklina EV, Meikle SF, Jamieson DJ, et al. Severe obstetric morbidity in the United States: 1998-2005. Obstet Gynecol 2009;113:293-299.
18. Callaghan WM, Mackay AP, Berg CJ. Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991-2003. Am J Obstet Gynecol 2008;199:e131-e138.
19. Lang CT, King JC. Maternal mortality in the United States. Best Pract Res Clin Obstet Gynaecol 2008;22:517-531.
20. Farquhar C, Sadler L, Masson V, et al. Beyond the numbers: classifying contributory factors and potentially avoidable maternal deaths in New Zealand, 2006-2009. Am J Obstet Gynecol 2011;205:331e331-e338. This analysis from the New Zealand confidential enquiry into maternal death described the development of a robust method to define preventability. Given the relatively small numbers analyzed, the estimates for the cause-specific mortality ratios reported in Table 3 are particularly imprecise for New Zealand.
21. Bouvier-Colle MH, Saucedo M, Deneux-Tharaux C. The confidential enquiries into maternal deaths, 1996-2006 in France: what consequences for the obstetrical care? J Gynecol Obstet Biol Reprod (Paris) 2011;40:87-102. The French confidential enquiry has been working for over a decade to reduce the rate of maternal mortality attributed to hemorrhage. This study, published in French, outlines their overall findings for the years 1996-2006.
22. Hawkins JL, Chang J, Palmer SK, et al. Anesthesia-related maternal mortality in the United States: 1979-2002. Obstet Gynecol 2011;117:69-74. This analysis of death certificates collected by the CDC suggests that for the years 1997-2002, in the USA, the case fatality rate from general anesthesia (6.5 per million general anesthetics for cesarean delivery) was not statistically different from the case fatality rate from neuraxial anesthesia (3.8 per million). Both techniques involve remote but real risks of maternal death.
23. Davies JM, Posner KL, Lee LA, et al. Liability associated with obstetric anesthesia: a closed claims analysis. Anesthesiology 2009;110:131-139.
24. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2007. Natl Vital Stat Rep 2010;58:1-85.
25. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. J Am Med Assoc 2012;307:483-490.
26. Yogev Y, Melamed N, Bardin R, et al. Pregnancy outcome at extremely advanced maternal age. Am J Obstet Gynecol 2010;203:558e551-e557.
27. Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol 2004;104:727-733.
28. Callaghan WM, Berg CJ. Pregnancy-related mortality among women aged 35 years and older, United States, 1991-1997. Obstet Gynecol 2003;102:1015-1021.
29. MacKay AP, Berg CJ, King JC, et al. Pregnancy-related mortality among women with multifetal pregnancies. Obstet Gynecol 2006;107:563-568.
30. Martin JA, Hamilton BE, Osterman MJK. Three decades of twin births in the United States, 1980-2009. NCHS data brief, no 80. Hyattsville, MD: National Center for Health Statistics;2012. This report from the National Center for Health Statistics describes the interactions between advanced maternal age, assisted reproductive technology and multiple gestation.
31. Bateman BT, Bansil P, Hernandez-Diaz S, et al. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol 2012;206:134e131-e138. This study analyzes the impact of chronic hypertension on a wide range of maternal morbidities and maternal death, and explores interactions between chronic hypertension, systemic lupus erythematosus and chronic renal failure on adverse maternal outcomes. Future analyses are needed to explore similar interactions to understand the combinations of conditions that are particularly detrimental to maternal health.
32. Martin J, Hamilton B, Ventura S, et al. Births: final data for 2009. Natl Vital Stat Rep 2011;60:1-104.
33. Kim SY, Dietz PM, England L, et al. Trends in prepregnancy obesity in nine states, 1993-2003. Obesity (Silver Spring) 2007;15:986-993.
34. Blomberg M. Maternal obesity and risk of postpartum hemorrhage. Obstet Gynecol 2011;118:561-568. This population-based cohort analysis of postpartum hemorrhage in Sweden found that maternal obesity increases risk for hemorrhage attributed to postpatum uterine atony, but does not increase risk for hemorrhage due to retained placenta.
35. Kayem G, Kurinczuk J, Lewis G, et al. Risk factors for progression from severe maternal morbidity to death: a national cohort study. PLoS One 2011;6:e29077. This analysis combined data from the UK Obstetric Surveillance System (UKOSS) and the UK Confidential Enquiry of maternal deaths to identify the demographic and clinical characteristics that increase risk of death as opposed to severe obstetric morbidity.
36. Kuklina E, Callaghan W. Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995-2006. BJOG 2011;118:345-352. This population-based cross-sectional analysis of the Nationwide Inpatient Sample in the USA estimates the incidence and trends of chronic heart disease among women admitted for childbirth, and the impact of each condition on severe obstetric morbidity.
37. Kuklina EV, Callaghan WM. Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004-2006. Obstet Gynecol 2010;115:93-100. A new ICD-9 code for peripartum cardiomyopathy was introduced in 2003, and this population-based cross-sectional analysis of the Nationwide Inpatient Sample in the USA focused on severe obstetric complications associated with peripartum cardiomyopathy and other myocardial disorders during delivery and postparutm hospitalizations.
38. Karamlou T, Diggs BS, McCrindle BW, Welke KF. A growing problem: maternal death and peripartum complications are higher in women with grown-up congenital heart disease. Ann Thorac Surg 2011;92:2193-2198; discussion 2198-2199. This population-based cross-sectional analysis of the Nationwide Inpatient Sample in the USA focused on diagnoses of congenital heart disease among women admitted for delivery. A diagnosis of ventricular septal defect (VSD) was associated with the highest risk of maternal death and complications.
39. Deneux-Tharaux C, Carmona E, Bouvier-Colle MH, Breart G. Postpartummaternal mortality and cesarean delivery. Obstet Gynecol 2006;108:541-548.
40. Clark SL, Belfort MA, Dildy GA, et al. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 2008;199:36e31-e35.
41. Mhyre JM, Bateman BT, Leffert LR. Influence of patient comorbidities on the risk of near-miss maternal morbidity or mortality. Anesthesiology 2011;115:963-972. This population-based cross-sectional analysis of the Nationwide Inpatient Sample in the USA found that risk for near-miss morbidity or maternal death is concentrated in less than 12% of the delivering population. Future clinical efforts to reduce maternal mortality must focus on optimizing care for these high-risk women.
42. Walker LO, Chesnut LW. Identifying health disparities and social inequities affecting childbearing women and infants. J Obstet Gynecol Neonatal Nurs 2010;39:328-338.
43. Saucedo M, Deneux-Tharaux C, Bouvier-Colle MH. Understanding regional differences in maternal mortality: a national case-control study in France. BJOG 2011 [Epub ahead of print]. This case-control study compared the quality and region of care for 328 French women who died postpartum, with a representative sample of control patients. Outcomes differed between regions, leading the authors to conclude that the organization and quality of care may play a role in the differential risk of maternal mortality between regions in France.
44. Bryant AS, Worjoloh A, Caughey AB, Washington AE. Racial/ethnic disparities in obstetric outcomes and care: prevalence and determinants. Am J Obstet Gynecol 2010;202:335-343. This review explores a wide range of racial and ethnic disparities in obstetric outcomes, and provides a useful theoretical framework to explain them; this framework includes five factors: genetic predisposition, behavior, social circumstances, environmental exposures, and differences in quality of care.
45. Tucker MJ, Berg CJ, Callaghan WM, Hsia J. The Black-White disparity in pregnancy-related mortality from 5 conditions: differences in prevalence and case-fatality rates. Am J Public Health 2007;97:247-251.
46. The California Pregnancy-Associated Mortality Review. Report from 2002 and 2003 Maternal Death Reviews. Sacramento: California Department of Public Health, Maternal Child and Adolescent Health Division;2011. Available at http://www.cdph.ca.gov/data/statistics/Documents/MO-CA-PAMRMaternalDeathReview- 2002-03.pdf, accessed February 25, 2012. Numerous states in the USA have maternal mortality review committees that ascertain and review all maternal deaths in the state in order to generate priorities and recommendations to improve future outcomes. Unfortunately, legal barriers limit the ability of individual states to share this data. The State of California has produced the most comprehensive report of any state.
47. Clark SL, Meyers JA, Frye DK, Perlin JA. Patient safety in obstetrics: the Hospital Corporation of America experience. Am J Obstet Gynecol 2011;204:283-287.
48. James A. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol 2011;118:718-729.
49. Clark SL, Hankins GD. Preventing maternal death: 10 clinical diamonds. Obstet Gynecol 2012;119:360-364. The Hospital Corporation of America is a private operator of healthcare facilities that oversees 17% of delivery centers in the USA, and undertakes regular centralized quality improvement-related reviews of maternal deaths. This review summarizes 10 recurrent errors that account for a disproportionate share of maternal deaths in this system, and suggests the development of local clinical protocols to reduce the effect of medical error on maternal mortality.
50. La Chapelle CF, Schutte JM, Schuitemaker NW, et al. Maternal mortality attributable to vascular dissection and rupture in the Netherlands: a nationwide confidential enquiry. BJOG 2012;119:86-93.
51. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-521.
52. Tanous D, Siu SC, Mason J, et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol 2010;56:1247-1253.
53. Kamiya CA, Iwamiya T, Neki R, et al. Outcome of Pregnancy and Effects on the Right Heart in Women With Repaired Tetralogy of Fallot. Circ J 2012. [Epub ahead of print]
54. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
55. OB Hemorrhage Protocol. OB Hemorrhage Care Guidelines: Checklist Format V.1.4. CMQCC Hemorrhage Task Force 2010. http://www.cmqcc.org/ob-hemorrhage, accessed January 4, 2012. This website-based toolkit produced by the California Maternal Quality Care Collaborative includes a wealth of protocols, best practices, and tools to guide system-based improvements to improve readiness, recognition, response, and reporting of obstetric hemorrhage.
56. Shields LE, Smalarz K, Reffigee L, et al. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products. Am J Obstet Gynecol 2011;205:368e361-e368. This community hospital in California implemented a full panel of system improvements recommended by the California Maternal Quality Care Collaborative and demonstrated improvements in both patient and institutional outcomes related to obstetric hemorrhage.